Archives: Agenda

Prize Draw taking place in exhibition hall at 14:15

Join us for a chance to win one of our prizes, including Apple products

• Exploring realistic AI applications across forecasting, inventory management and distribution planning for Korean and regional trials
• Keeping pace with fast-moving AI development while maintaining trial integrity and regulatory alignment
• AI, data and the changing role of the CRO/vendor in Korea’s clinical supply ecosystem

• Moving beyond transactional oversight toward a genuine strategic partnership model
• Aligning financial incentives so both sponsor and CRO win when a trial performs well
• Leveraging joint innovation initiatives (AI, digital tools, process redesign) as a partnership accelerant rather than a point of friction
• Defining what “great” actually looks like from both the sponsor’s and the CRO’s perspective before trying to get there

• Overcoming the latest challenges in global cold chain logistics for clinical trials
• Identifying common risks and mitigation strategies for international temperature-controlled shipments
• Leveraging real-time temperature monitoring and digital technologies to enhance shipment visibility

• Assessing the existing clinical evidence and data gaps when taking on a licensed-in asset
• Translating the asset’s development strategy into an optimized clinical trial design
• Aligning internal teams, external partners, and investigators to accelerate study start-up and first-patient-in

• How the growth of domestic Korean CROs is reshaping vendor selection
• Supply chain capability comparisons between local and global CRO, CMO, CDMO offerings
• Where domestic CROs are closing the gap on international standards

• Addressing common operational and scientific challenges in Phase 1 and Phase 2 trials
• Managing complex protocol designs incorporating biomarkers and adaptive trial elements
• Evaluating the necessity of placebo groups in Phase 1 studies